Search

The article discusses the protest against the Tugwell Food and Drug Bill in the U.S. Protestors argue that the bill is just a way to place the food and drug sectors under the domination of the Secretary of Agriculture. A Senate committee will hear the provisions of the bill which is expected to affect several sectors including food, drugs and cosmetics.

The article offers news briefs in the U.S. Critics of the Food & Drug Administration have been accusing the agency of quick approval of some drugs such as menadione (K-3) and the vapor anesthetic Flouthane which are not recommended for several years. J. W. Van Gorkom has been named president of Union Tank Car Co. to succeed Edwin A. Locke Jr. Thomas Mellon Evans has lost his bid for the control of Brown Co., a paper company in Berlin, New Hampshire.

The article offers a look into the obscurity of mifepristone, an abortion pill developed by French pharmaceutical firm Roussel Uclaf, since its approval by the U.S. Food and Drug Administration (FDA) in 2000. It attributes the obscurity of the pill to regulatory restrictions known as risk evaluation and mitigation strategy (REMS) that included prescribing. It explores implication of the U.S. Supreme Court's possible overturn of the Roe v. Wade abortion rights ruling on the sale of mifepristone.

The article focuses on the enactment of a federal food and drug law in the U.S. requiring cleanliness standards for food handlers by wearing clean and washable clothing that was recognized at the meeting of the Linen Supply Association in Cincinnati, Ohio.

A letter to the editor is presented to the article "An Economist for the Common Man," by Gary Becker in the October 26, 1992 issue.

The article reports on discussions between New York Mayor Fiorello La Guardia and those of the pharmaceutical, cosmetics and advertising industries regarding the imposition of the Copeland bill as of November 1935. The bill, which takes effect in March 1936, requires manufacturers to submit their advertising campaigns to the New York Board of Health prior to launching or have their licenses revoked. Industry officials also asked for changes to be made on the New York Sanitary Code, but the mayor told them to focus on the bill first.

Presents a market outlook for the U.S. pharmaceutical industry in 1985. Expected increase in the sales and profits of pharmaceutical companies; Factor that reduced new drug profits in the U.S.; Drug development regulations implemented by the U.S. Food and Drug Administration; Potential factor that made domestic drug volume essentially flat.

The article offers business news briefs in 1977 including the near completion of a joint venture agreement between Reckitt & Coleman (R&C) Ltd., and Mortin-Norwich Products Inc., the indictment of three sugar refiners and one corporation for price fixing on more than 250 million U.S. dollars worth of cane sugar, and the reaffirmation of the U.S. Supreme Court that states are not to impose additional regulation on food, drug, and cosmetics already covered by federal labeling laws.

The article discusses a new statute that would amend the U.S. Food and Drug Act and protect truth in advertising involving products that affect public health. It says that the bill will require companies to label their products with full information on ingredients, will prohibit the adulteration of drugs and will install a permit system for products that may be dangerous to public health. It adds that the statute will give more power to government in fighting companies who deceive the public through false advertising.

The article reports on the confidence of the U.S. Food and Drug Administration (FDA) on not having the Elixir Sulfanilamide disaster in 1937 repeated in effect to the new law requirement approval of all new drugs.

The article reports on the prospective creation of a consumer safety agency in the U.S. despite the objections of the administration of U.S. President Richard Nixon and industry groups. It is expected that the agency will be carved out of the U.S. Health, Education and Welfare Department. Bills sponsored by legislators John E. Moss and Warren G. Magnuson focus on a super-agency that could inspect factories and subpoena a manufacturer's records in safety investigations. Legislation is also proposed regarding the agency's regulation of food and drugs.